...
Registration number: ПИ №ФС77-235В7,
8th March 2008. ISSN: 1815-445X
8th March 2008. ISSN: 1815-445X
Cell Technologies in Hybrid Surgery of Chronic Cardiac Insufficiency
HTML
PDFState Research Institute of Cardiology of the Tomsk Scientific Center, SB RAMS
Keywords:
heart insufficiency, cellular technologies, cardiac surgery
heart insufficiency, cellular technologies, cardiac surgery
Analysis of clinical experience of autologous mononuclear bone marrow cells
CMBMCJ and fetal cells iFC) use in combination with surgical methods of
treatment in patients ischemic cardiomyopathy was made. A year of prospective
follow-up period showed that methods of stem cells introduction are safe and
well-tolerated by patients. Positive effect of the intervention performed on
the course of coronary and heart insufficiency was noticed. Ultrasonic
examination showed that improved values of intracardiac hemodynamic was noticed
only in the patients after treatment with fetal cells in comparison with the
control group of patients and with the group of patients treated with MBMC.
Unfortunetely, only registered users are allowed to leave comments.
1. Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю., Сычев А.В., Саидова М.О. Стволовые клетки и их применение для регенерации миокарда. Сердечная недостаточность 2003; 4(41: 168-73.
2. Orlic D., Kajstura J., Chimenti S.et al. Bone marrow cells regenerate infracted myocardium. Nature 2001; 410: 701-5.
3. Бокерия Л.А., Георгиев Г.П., Голухова Е.З. и др. Клеточные и интерактивные технологии в лечении врожденных и приобретенных пороков сердца и ишемической болезни сердца. Вестник РАМН 2004; 9: 48-55.
4. Boyum A. Separation of leucocyties from blood and bone marrow. Scandinavian J of clinical and laboratory investigation 1ЭБ8; 21, suppl. 97: 91-106.
5. Гольдберг Е.Д. Справочник по гематологии. Изд-во Томского государственного университета; 1989: 370.
6. Tomita S., Mickle D.A., Weisel R.V. et al. Improved heart function with myogenesis and angiogenesis after autologus porcine marrow stromal cell transplantation. J. Thorac. Cardiovasc. Surg. 2002; 123: 1132-5.
7. Ахмедов Ш.Д., Бабокин B.E., Рябов В.В. с др. Клинический опыт применения аутологичных мононулеарных клеток костного мозга в лечении больных с ишемической болезнью сердца и дилятационной кардиомиопатией. Кардиология 2006; 7: 10-4.
8. Lishmanov Y.B., Sazonova S.I., Chernov V.I. et al. Tracking of autologous mononuclear bone marrow cells after intracoronary infusion by direct labeling with 99mTc-HMPAO in patients with cardiac disease. Abstract. Europ. J. Nucl. Med.Mol. Imaging 2004; 31, Suppl. 2: S321.
9. Tarasov A.I., Petrenko A.Y., Jones D.R., Grischenko V.I. Phenotypic analysis colony-forming activity of cryopreserved hemopoietic cells in human fetal liver. Exp. Oncol. 2002; 24: 180-3.
10. Абдулкадыров K.M., Балашова В.А. Клеточный состав печени и селезенки в фетальном периоде. Клеточная трансплантология и тканевая инженерия 2008; 3(1]: 46-8.
11. Петренко Ю.А. Иммунорегуляторные свойства клеток фетальной печени человека. Клеточная трансплантология и тканевая инженерия 2007; 2(3): 57-61.
12. Grischenko V.I., Tarasov A.I., Rudenko S.V., Petrenko A.Y. The sensitivity of human fetal liver cells of 7-12 weeks of gestation to programmed freezing and cyclic freeze-thawing. Probl. Cryobiol. 2000; 4: 37-44.